XML 28 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 8,062 $ 9,676
Short-term investments 0 774
Accounts receivable (net of allowance for doubtful accounts of $85 in 2020 and $86 in 2019) 7,851 6,778
Inventories (excludes inventories of $2,197 in 2020 and $1,480 in 2019 classified in Other assets - see Note 7) 6,310 5,978
Other current assets 5,541 4,277
Total current assets 27,764 27,483
Investments 785 1,469
Property, Plant and Equipment (at cost)    
Land 350 343
Buildings 12,645 11,989
Machinery, equipment and office furnishings 16,649 15,394
Construction in progress 7,324 5,013
Property, plant and equipment (at cost) 36,968 32,739
Less: accumulated depreciation 18,982 17,686
Property, plant and equipment, net 17,986 15,053
Goodwill 20,238 19,425
Other Intangibles, Net 14,604 14,196
Other Assets 10,211 6,771
Total Assets 91,588 84,397
Current Liabilities    
Loans payable and current portion of long-term debt 6,431 3,610
Trade accounts payable 4,594 3,738
Accrued and other current liabilities 13,053 12,549
Income taxes payable 1,575 736
Dividends payable 1,674 1,587
Total current liabilities 27,327 22,220
Long-Term Debt 25,360 22,736
Deferred Income Taxes 1,015 1,470
Other Noncurrent Liabilities 12,482 11,970
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019 1,788 1,788
Other paid-in capital 39,588 39,660
Retained earnings 47,362 46,602
Accumulated other comprehensive loss (6,634) (6,193)
Stockholders' equity before deduction for treasury stock 82,104 81,857
Less treasury stock, at cost: 1,046,877,695 shares in 2020 and 1,038,087,496 shares in 2019 56,787 55,950
Total Merck & Co., Inc. stockholders’ equity 25,317 25,907
Noncontrolling Interests 87 94
Total equity 25,404 26,001
Total Liabilities and Equity $ 91,588 $ 84,397